Celcuity Inc (CELC) Q3 2024 Earnings Call Highlights: Clinical Milestones and Financial Challenges

By Yahoo! Finance | Nov 15, 2024 at 02:24 AM EST

The CEO discussed the event rate and timeline shift in the earnings call. The event rate is influenced by patient responses to therapies, affecting the timeline. Roche's new therapy approval won't impact their target population for endocrine treatment-sensitive patients.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.